(Total Views: 171)
Posted On: 08/18/2023 2:55:00 AM
Post# of 35
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
81 lesions treated across four feasibility trials of head and neck or skin cancers demonstrated 89% complete response rate.
Two-year local recurrence-free survival rate of 77%.
https://www.globenewswire.com/news-release/20...-DaRT.html
Two-year local recurrence-free survival rate of 77%.
https://www.globenewswire.com/news-release/20...-DaRT.html
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)